A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy-Science-Chemical Encyclopedia-lookchem

A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy
Add time:09/02/2019 Source:sciencedirect.com

AimThe aim of the present study was to develop nanoproliposomes of lercanidipine, in order to overcome its poor biopharmaceutical properties and to improve its therapeutic efficacy in treating hypertension.

We also recommend Trading Suppliers and Manufacturers of Lercanidipine hydrochloride (cas 132866-11-6). Pls Click Website Link as below: cas 132866-11-6 suppliers

Prev:Research paperDevelopment of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation
Next: RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a)

Encyclopedia